DAVID GUERRERO: Open Payments
NPI 1265561849 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,189 in 82 payments from 12 companies in 2025. Trend: 2023 $1,166 · 2024 $1,089 · 2025 $1,189
Food & beverage: $1,189
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 18 | $248 |
| Novo Nordisk Inc | 14 | $213 |
| Bayer Healthcare Pharmaceuticals Inc. | 13 | $168 |
| Otsuka America Pharmaceutical, Inc. | 16 | $163 |
| AstraZeneca Pharmaceuticals LP | 5 | $92 |
| Lundbeck LLC | 3 | $68 |
| Dexcom, Inc. | 3 | $59 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $58 |
| Exact Sciences Corporation | 2 | $45 |
| Astellas Pharma US Inc | 2 | $32 |
Products named: REXULTI, Kerendia, KISUNLA, JARDIANCE, Ozempic, Dexcom G6 Transmitter, XIFAXAN, AIRSUPRA.
Industry payments across TX — which companies pay providers there.
